Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Gökçen Demiray A"'
Autor:
Melek ÖZDEMİR, Gamze GÖKOZ DOĞU, Burcu YAPAR TAŞKÖYLÜ, Atike Gökçen DEMİRAY, Burçin ÇAKAN DEMİREL, Tolga DOĞAN, Taliha GÜÇLÜ KANTAR, Arzu YAREN, Serkan DEĞİRMENCİOĞLU, Semra TAŞ, Bedriye AÇIKGÖZ YILDIZ, Gamze Serin ÖZEL
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 12, Iss 3, Pp 155-162 (2024)
Aim: According to the information obtained from the World Health Organization database, the incidence of hepatocellular carcinoma (HCC) in Turkey increased by 17.78% between the years of 2018 and 2020. In this study, we investigated the prognostic va
Externí odkaz:
https://doaj.org/article/991712c2587e49699349f14a0eeb8977
Autor:
Atike Gökçen Demiray, Aydın Demiray, Arzu Yaren, Burcu Taşköylü, Gamze Gököz Doğu, Serkan Değirmencioğlu, Umut Çakıroğlu, Nail Özhan, Canan Karan, Burçin Çakan Demirel, Tolga Doğan, Melek Özdemir
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 33, Iss 8, Pp 696-703 (2022)
Externí odkaz:
https://doaj.org/article/161a9eb498124b999615efef94d858c9
Autor:
Atike Gökçen Demiray, Arzu Yaren, Uğur Sungurtekin, Papatya Bahar Baltalarlı, Neşe Demirkan, Duygu Herek, Burcu Yapar Taşköylü, Gamze Gököz Doğu, Serkan Değirmencioğlu, Utku Özgen, Halil Sağınç, Umut Çakıroğlu, Nail Özhan, Canan Karan, Burçin Çakan Demirel, Tolga Doğan, Melek Özdemir
Publikováno v:
Journal of Oncology. 2022:1-8
Aim. The current standard treatment of locally advanced rectal carcinoma is total mesorectal excision and postoperative adjuvant chemotherapy after neoadjuvant concurrent chemoradiotherapy (NCRT). Many studies have shown that pathological complete re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b612e4fb8a71b3899a9c45ea1ada4a3
https://doi.org/10.1155/2022/4108677
https://doi.org/10.1155/2022/4108677
Autor:
Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse, Bala Başak Öven, Başak Oyan Uluç, Atike Gökçen Demiray, Dilek Erdem, Bilgin Demir, Nazım Serdar Turhal, Necdet Üskent, Sinem Akbaş, Fatih Selçukbiricik, Ali İnal, Ahmet Bilici, Ömer Fatih Ölmez, Devrim Çabuk, Çağlar Ünal, Mutlu Hızal, Mehmet Ali Nahit Şendur, Mustafa Korkmaz, Nuri Karadurmuş, İsmail Ertürk, Sema Sezgin Göksu, Ali Murat Tatlı, Deniz Can Güven, Saadettin Kılıçkap, Nail Paksoy, Adnan Aydıner, Havva Yeşil Çınkır, Özlem Özkul, Akın Öztürk, Sevinç Ballı, Yasemin Kemal, Atike Pınar Erdoğan, Özlem Er, Perran Fulden Yumuk, Ahmet Demirkazık
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:3547-3555
Purpose Atezolizumab has been shown to be effective and safe in randomized trial in the first-line treatment of extensive-stage small cell lung cancer (SCLC). However, there are limited real-life data on atezolizumab. In this study, we aimed to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a345459815bcd72a8a16fb661d35462
https://doi.org/10.1007/s00432-022-04087-x
https://doi.org/10.1007/s00432-022-04087-x
Autor:
Tolga DOĞAN, Arzu YAREN, Atike Gökçen DEMİRAY, Burcu YAPAR TAŞKÖYLÜ, Burçin ÇAKAN DEMİREL, Melek ÖZDEMİR, Taliha GÜÇLÜ KANTAR, Serkan DEĞİRMENCİOĞLU, Gamze GOKOZ DOGU
Publikováno v:
Pamukkale Medical Journal.
Purpose:We evaluated the effect of pre-treatment inflammation response markers on overall survival (OS) and progression-free survival (PFS) in patients with locally advanced unresectable and metastatic gastric cancer. Material and Method:Patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a28486ae180e30cbcb45c05bad81fb5
https://doi.org/10.31362/patd.1265291
https://doi.org/10.31362/patd.1265291
Autor:
Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
Publikováno v:
Cancer Investigation. 39:473-481
Aim: The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment. Method: Retrospective analysis of T-DM1 results of human epidermal grow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e995dc25bd5d60e4fc0b04e58d82c9ea
https://doi.org/10.1080/07357907.2021.1933011
https://doi.org/10.1080/07357907.2021.1933011
Autor:
Atike Gökçen Demiray, Hakan Akca, Burcu Yapar, Aysegul Kargi, Aydın Demiray, Gamze Gokoz Dogu, Ozgur Tanriverdi, Ahmet Ergin, Can Ozlu, Arzu Yaren
Publikováno v:
Volume: 8, Issue: 1 13-17
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
Bu çalışmada ileri evre mide kanserli Türk hastalarda XPD/ERCC2, RAD51 ve hOGG1 gen polimorfizminin prognoz üzerine etkisinin olup olmadığını değerlendirdik. Çalışmaya performans durumu 0-2 olan, inoperabl lokal ileri veya uzak metastazl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e12329962cd4966a0b985b146bf550
https://doi.org/10.47572/muskutd.676049
https://doi.org/10.47572/muskutd.676049
Autor:
Atike Gökçen Demiray, Arzu Yaren, Burcu Yapar Taşköylü, Serkan Değirmencioğlu, Gamze Gököz Doğu
Publikováno v:
Dicle Medical Journal, Vol 48, Iss 1, Pp 163-170 (2021)
Objective: Glioblastoma Multiforme (GBM) is the most common primary malignant brain tumor in adults. Optimal treatment is adjuvant concomitant chemoradiotherapy following the widest possible surgical resection (maximum safe resection) followed by adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2cffb09d35db5ed48c6fbd6e92fe2832
Autor:
Burcu Yapar Taskoylu, Atike Gökçen Demiray, Serkan Değirmencioğlu, Gamze Gököz Doğu, Arzu Yaren
Publikováno v:
Volume: 48, Issue: 1 163-170
Dicle Tıp Dergisi
Dicle Tıp Dergisi
Amaç: Glioblastoma Multiforme (GBM) erişkinlerde en sık görülen primer malign beyin tümörüdür. Optimal tedavisi, mümkün olan en geniş cerrahi rezeksiyon (maksimum güvenli rezeksiyon) sonrasında adjuvan eşzamanlı kemoradyoterapi ve ard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41610a4a14a88541b70c760dd46a7701
https://doi.org/10.5798/dicletip.887660
https://doi.org/10.5798/dicletip.887660
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.